Squarepoint’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17,431
| Closed | -$398K | – | 3077 |
|
|
2024
Q4 | $398K | Buy |
17,431
+12,451
| +250% | +$285K | ﹤0.01% | 2059 |
|
|
2024
Q3 | $209K | Buy |
+4,980
| New | +$209K | ﹤0.01% | 2155 |
|
|
2021
Q1 | – | Sell |
-839
| Closed | -$237K | – | 2887 |
|
|
2020
Q4 | $237K | Buy |
839
+111
| +15% | +$31.4K | ﹤0.01% | 2027 |
|
|
2020
Q3 | $175K | Buy |
+728
| New | +$175K | ﹤0.01% | 1983 |
|
|
2019
Q3 | – | Sell |
-748
| Closed | -$35K | – | 2450 |
|
|
2019
Q2 | $35K | Buy |
+748
| New | +$35K | ﹤0.01% | 2226 |
|
|
2018
Q4 | – | Sell |
-1,060
| Closed | -$62K | – | 2125 |
|
|
2018
Q3 | $62K | Sell |
1,060
-1,158
| -52% | -$67.7K | ﹤0.01% | 1908 |
|
|
2018
Q2 | $118K | Buy |
2,218
+858
| +63% | +$45.6K | ﹤0.01% | 1626 |
|
|
2018
Q1 | $383K | Buy |
+1,360
| New | +$383K | 0.01% | 1193 |
|